Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bio Green Med Solution (BGMS) FCF Margin (2016 - 2025)

Historic FCF Margin for Bio Green Med Solution (BGMS) over the last 12 years, with Q3 2025 value amounting to 535.8%.

  • Bio Green Med Solution's FCF Margin rose 301342000.0% to 535.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 7522.22%, marking a year-over-year increase of 67264300.0%. This contributed to the annual value of 18581.4% for FY2024, which is 147437800.0% down from last year.
  • Bio Green Med Solution's FCF Margin amounted to 535.8% in Q3 2025, which was up 301342000.0% from 30670.0% recorded in Q3 2024.
  • Bio Green Med Solution's 5-year FCF Margin high stood at 349.87% for Q2 2023, and its period low was 77100.0% during Q2 2024.
  • Moreover, its 3-year median value for FCF Margin was 12612.9% (2023), whereas its average is 21165.58%.
  • Its FCF Margin has fluctuated over the past 5 years, first crashed by -767501300bps in 2024, then skyrocketed by 301342000bps in 2025.
  • Bio Green Med Solution's FCF Margin (Quarter) stood at 12612.9% in 2023, then plummeted by -143bps to 30670.0% in 2024, then surged by 98bps to 535.8% in 2025.
  • Its FCF Margin was 535.8% in Q3 2025, compared to 30670.0% in Q3 2024 and 77100.0% in Q2 2024.